| Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients J Yan, B Zhang, S Zhang, J Cheng, X Liu, W Wang, Y Dong, L Zhang, ... NPJ Precision Oncology 5 (1), 72, 2021 | 66 | 2021 |
| Long noncoding RNA SOX21‐AS1 promotes cervical cancer progression by competitively sponging miR‐7/VDAC1 X Zhang, X Zhao, Y Li, Y Zhou, Z Zhang Journal of cellular physiology 234 (10), 17494-17504, 2019 | 57 | 2019 |
| Pan-cancer analysis shows that ALKBH5 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including gliomas C Wei, B Wang, D Peng, X Zhang, Z Li, L Luo, Y He, H Liang, X Du, S Li, ... Frontiers in immunology 13, 849592, 2022 | 53 | 2022 |
| A novel tumor-suppressor, CDH18, inhibits glioma cell invasiveness via UQCRC2 and correlates with the prognosis of glioma patients Y Bai, Y Zhan, B Yu, WW Wang, L Wang, J Zhou, R Chen, F Zhang, ... Cellular Physiology and Biochemistry 48 (4), 1755-1770, 2018 | 43 | 2018 |
| Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activities J Yan, Y Zhao, Y Chen, W Wang, W Duan, L Wang, S Zhang, T Ding, L Liu, ... EBioMedicine 72, 2021 | 42 | 2021 |
| TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas ZY Zhang, AKY Chan, XJ Ding, ZY Qin, CS Hong, LC Chen, X Zhang, ... Oncotarget 6 (28), 24871, 2015 | 41 | 2015 |
| Radiomic features from multi-parameter MRI combined with clinical parameters predict molecular subgroups in patients with medulloblastoma J Yan, L Liu, W Wang, Y Zhao, KKW Li, K Li, L Wang, B Yuan, H Geng, ... Frontiers in Oncology 10, 558162, 2020 | 40 | 2020 |
| Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis ZY Zhang, AKY Chan, HK Ng, XJ Ding, YX Li, ZF Shi, W Zhu, P Zhong, ... International journal of clinical and experimental pathology 7 (12), 8627, 2014 | 39 | 2014 |
| Clinical and mutational profiles of adult medulloblastoma groups GCH Wong, KKW Li, WW Wang, APY Liu, QJ Huang, AKY Chan, ... Acta Neuropathologica Communications 8 (1), 191, 2020 | 37 | 2020 |
| Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy ZY Zhang, J Xu, Y Ren, Y Yao, KKW Li, HK Ng, Y Mao, LF Zhou, P Zhong PLoS One 9 (6), e99490, 2014 | 31 | 2014 |
| Incremental prognostic value and underlying biological pathways of radiomics patterns in medulloblastoma J Yan, S Zhang, KKW Li, W Wang, K Li, W Duan, B Yuan, L Wang, L Liu, ... EBioMedicine 61, 2020 | 29 | 2020 |
| Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas QHW Wong, KKW Li, WW Wang, TM Malta, H Noushmehr, Y Grabovska, ... Modern Pathology 34 (7), 1245-1260, 2021 | 27 | 2021 |
| Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas ZY Zhang, YB Zhan, FJ Zhang, B Yu, YC Ji, JQ Zhou, YH Bai, YM Wang, ... Aging (Albany NY) 11 (16), 6252, 2019 | 24 | 2019 |
| Regulation of UHRF1 by microRNA-378 modulates medulloblastoma cell proliferation and apoptosis ZY Zhang, B Zhu, XW Zhao, YB Zhan, JJ Bao, JQ Zhou, FJ Zhang, B Yu, ... Oncology reports 38 (5), 3078-3084, 2017 | 21 | 2017 |
| Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with the prognosis of group 3 and group 4 medulloblastoma K Li, W Duan, H Zhao, L Wang, W Wang, Y Zhan, T Sun, F Zhang, B Yu, ... Scientific Reports 9 (1), 13239, 2019 | 20 | 2019 |
| Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases C Tang, Z Zhang, L Chen, Z Sun, Y Zhang, Z Qin, Y Yao, L Zhou Journal of neuro-oncology 126, 499-507, 2016 | 19 | 2016 |
| Radiomics and qualitative features from multiparametric MRI predict molecular subtypes in patients with lower-grade glioma C Sun, L Fan, W Wang, W Wang, L Liu, W Duan, D Pei, Y Zhan, H Zhao, ... Frontiers in Oncology 11, 756828, 2022 | 18 | 2022 |
| CircRNA: An emerging star in the progression of glioma D Peng, L Luo, X Zhang, C Wei, Z Zhang, L Han Biomedicine & Pharmacotherapy 151, 113150, 2022 | 17 | 2022 |
| Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study ZC Li, J Yan, S Zhang, C Liang, X Lv, Y Zou, H Zhang, D Liang, Z Zhang, ... European Radiology 32 (8), 5719-5729, 2022 | 16 | 2022 |
| Predicting 1p/19q co-deletion status from magnetic resonance imaging using deep learning in adult-type diffuse lower-grade gliomas: a discovery and validation study J Yan, S Zhang, Q Sun, W Wang, W Duan, L Wang, T Ding, D Pei, C Sun, ... Laboratory Investigation 102 (2), 154-159, 2022 | 16 | 2022 |
Ying MaoHua Shan Hospital, Fudan University在 fudan.edu.cn 的电子邮件经过验证
